Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Heindel
Josef Heindel, Hainburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20090139861 | MAGNETIC SHUNTS IN TUBULAR TARGETS - A sputter target has a carrier body and a target material arranged on the carrier body, wherein the carrier body has a rear surface facing away from the target material and the target material has a front surface facing away from the carrier body. A ferromagnetic material is arranged between the front surface and the rear surface. | 06-04-2009 |
Ned Heindel, Easton, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120010168 | Unique Dual-Action Therapeutics - A new family of therapeutics which provides a controlled-release delivery platform for non-steroidal anti-inflammatory agents on an ester or an ester-carbonate backbone is disclosed herein. These agents are reversible inhibitors of acetylcholinesterase and are thus useful for clinical conditions benefiting from inflammation suppression and cholinergic intervention. These compounds are of the general formula wherein n=0, 1; X═C, Si, and N+ and NSAID=ibuprofen, naproxen, indomethacin and diclofenac. Other embodiments are also disclosed. | 01-12-2012 |
Ned D. Heindel, Easton, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20110059935 | Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS - Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin V | 03-10-2011 |
Ned D. Heindel, Bethlehem, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090155224 | Dimethyl amino ethyl ether psoralens and methods for their production and use - Water-soluble dimethyl amino ethyl ether psoralens useful in the treatment of proliferative skin disorders, microbial infections and diseases, disorders of the blood and bone marrow of mammals and in microbiocidal compositions for sterilization of blood and blood products and surgical implants and inhibition of microbial growth in industrial applications are provided. | 06-18-2009 |